H.R. 1660 115th Congress House

Global Health Innovation Act of 2017

Official title: To direct the Administrator of the United States Agency for International Development to submit to Congress a report on the development and use of global healt… Show full official titleShow less

Official title: To direct the Administrator of the United States Agency for International Development to submit to Congress a report on the development and use of global health innovations in the programs, projects, and activities of the Agency.

Introduced: July 19, 2017 See on congress.gov

International Affairs Child healthCongressional oversightDrug therapyForeign aid and international relief

More subjectsShow fewer subjects

HIV/AIDSHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesMedical tests and diagnostic methodsProduct development and innovationPublic-private cooperationU.S. Agency for International Development (USAID)Women's healthWorld health

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

Everywhere this bill has been 21 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jan 3, 2019

Became Public Law No: 115-411.

Jan 3, 2019

Signed by President.

Dec 27, 2018

Presented to President.

Dec 21, 2018

Message on Senate action sent to the House.

Dec 20, 2018

Passed Senate without amendment by Unanimous Consent. (consideration: CR S8002)

Dec 20, 2018

Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S8002)

Mar 22, 2018

Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.

Mar 22, 2018

Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.

Mar 20, 2018

Committee on Foreign Relations. Ordered to be reported without amendment favorably.

Jan 19, 2018

Received in the Senate and Read twice and referred to the Committee on Foreign Relations.

Jan 18, 2018

Motion to reconsider laid on the table Agreed to without objection.

Jan 18, 2018

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34). (text: CR 1/17/2018 H439)

Jan 18, 2018

Considered as unfinished business. (consideration: CR H538-539)

Jan 17, 2018

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

Jan 17, 2018

DEBATE - The House proceeded with forty minutes of debate on H.R. 1660.

Jan 17, 2018

Considered under suspension of the rules. (consideration: CR H439-440)

Jan 17, 2018

Mr. Royce (CA) moved to suspend the rules and pass the bill.

Sep 28, 2017

Committee Consideration and Mark-up Session Held.

Sep 28, 2017

Ordered to be Reported by Voice Vote.

Mar 21, 2017

Referred to the House Committee on Foreign Affairs.

Mar 21, 2017

Introduced in House

Votes taken on this bill 1

Date	Chamber	What was voted on	Result	Yes–No
Jan 18, 2018	House · vote #34	On Motion to Suspend the Rules and Pass	Passed	423–3	See who voted →

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action January 3, 2019

Became Public Law No: 115-411.

Plain-English summary Congressional Research Service

Global Health Innovation Act of 2017

This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Bill text 6 versions

Engrossed in House Formatted Text PDF Formatted XML
Enrolled Bill Formatted Text PDF Formatted XML
Introduced in House Formatted Text PDF Formatted XML
Public Law Formatted Text PDF United States Legislative Markup
Referred in Senate Formatted Text PDF Formatted XML
Reported to Senate Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 2

Foreign Affairs Committee
House of Representatives
Foreign Relations Committee
Senate

Cosponsors 16

California · Sep 18, 2017

California · Jul 19, 2017

Velázquez, Nydia M.

New York · Jul 19, 2017

Beatty, Joyce

Ohio · May 2, 2017

DelBene, Suzan K.

Washington · Apr 20, 2017

Diaz-Balart, Mario

Florida · Mar 21, 2017

Donovan, Daniel

· Mar 21, 2017

Keating, William R.

Massachusetts · Mar 21, 2017

ROS-LEHTINEN, ILEANA

· Mar 21, 2017

Sherman, Brad

California · Mar 21, 2017

Smith, Christopher H.

New Jersey · Mar 21, 2017

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 1660: Global Health Innovation Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1660/

MLA

"H.R. 1660: Global Health Innovation Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1660/.

Bluebook (legal)

H.R. 1660, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1660/.

Markdown link

[H.R. 1660: Global Health Innovation Act of 2017](https://openamerica.io/bill/115-HR-1660/)